Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Crypto Market Recap: Bitcoin Price Hits New All-time... May 22, 2025 Appointment of Managing Director July 29, 2025 Resolution Minerals LtdTo Develop U.S. Government Engagement Strategy... June 18, 2025 Crypto Market Update: GENIUS Act Becomes First Federal... July 21, 2025 Critical Metals Secures US$120 Million Loan LOI for... June 20, 2025 Exceptional Lithium Intercept Extends Red Mountain Discovery Further... May 19, 2025 Lithium Universe LtdInterview with Executive Chairman July 5, 2025 Silver Price Update: Q2 2025 in Review July 17, 2025 Crypto Market Recap: Bitcoin Breaks US$111,000, Trump Courts... May 24, 2025 175m @ 2.5% Copper from 7.6m, Hole Ends... May 6, 2025